SMMT - Financial Reports List - Summit Therapeutics Inc. - IntrinsicAlpha

Summit Therapeutics Inc. SMMT

Healthcare - Biotechnology - NASDAQ - US

$ 17.32

-0.23 %

$ 12.8 B

Market Cap

-55.87

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	100.00%	-67.37%	-81.20%
Annual Report	FY	10-K	2024-12-31	0.00%	64.01%	100.35%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-164.50%	-21929.81%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-310.31%	-183.46%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	91.98%	92.11%
Quarterly Report	Q4	8-K	2023-12-31	-33333.33%	-123.99%	-78.38%
Annual Report	FY	10-K	2023-12-31	0.00%	-726.73%	-24.48%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	17.66%	101.56%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	12.25%	-24.44%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-2528.30%	-2324.20%

1